![PE142000: α-GalNAc-PEG4-Acid label-new 2-[2-(2-Azidoethoxy)ethoxy]ethyl β-D-glucopyranoside](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/PE142000-R_e0a7469d-edbc-4282-87d4-86a6ff3d3063.svg?v=1700577213)
Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
2-[2-(2-Azidoethoxy)ethoxy]ethyl β-D-glucopyranoside
HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 Hydrochloride
/ β-D-Lac-Butyl-Carboxylic Acid / β-Lac-Bu-CO2H
Tri-GalNAc-PEG5-COOH
05 / HIV Infection / Elbasvir-d6 / Trideuteriomethyl N-[(2S)-3-methyl-1-[(2S)-2-[5-[(6S)-3-[2-[(2S)-1-[(2S)-3-methyl-2-(trideuteriomethoxycarbonylamino)butanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]-6-phenyl-6H-indolo[1
PE142000: α-GalNAc-PEG4-Acid label-new 2-[2-(2-Azidoethoxy)ethoxy]ethyl β-D-glucopyranosideC17H31NO11 425. 43 An D N acetylgalactosamine (GalNAc) ligand equipped with a terminal carboxylic acid through a hydrophilic PEG4 spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form amide bonds. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the
US$ 279.00
US$ 44.99
US$ 11.99
